Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112 USD | -1.03% | +0.72% | -8.93% |
13/05 | US reclassification could drive fresh research funding into pot sector | RE |
07/05 | Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.93% | 713.42Cr | |
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Needham Adjusts Jazz Pharmaceuticals' Price Target to $225 From $226, Maintains Buy Rating